202 related articles for article (PubMed ID: 9192645)
21. Induced pocket to accommodate the cell attachment Arg-Gly-Asp motif in a neutralizing antibody against foot-and-mouth-disease virus.
Verdaguer N; Mateu MG; Bravo J; Domingo E; Fita I
J Mol Biol; 1996 Feb; 256(2):364-76. PubMed ID: 8594203
[TBL] [Abstract][Full Text] [Related]
22. A multiply substituted G-H loop from foot-and-mouth disease virus in complex with a neutralizing antibody: a role for water molecules.
Ochoa WF; Kalko SG; Mateu MG; Gomes P; Andreu D; Domingo E; Fita I; Verdaguer N
J Gen Virol; 2000 Jun; 81(Pt 6):1495-505. PubMed ID: 10811933
[TBL] [Abstract][Full Text] [Related]
23. Tolerance to mutations in the foot-and-mouth disease virus integrin-binding RGD region is different in cultured cells and in vivo and depends on the capsid sequence context.
Gutiérrez-Rivas M; Pulido MR; Baranowski E; Sobrino F; Sáiz M
J Gen Virol; 2008 Oct; 89(Pt 10):2531-2539. PubMed ID: 18796722
[TBL] [Abstract][Full Text] [Related]
24. Use of substituted and tandem-repeated peptides to probe the relevance of the highly conserved RGD tripeptide in the immune response against foot-and-mouth disease virus.
Novella IS; Borrego B; Mateu MG; Domingo E; Giralt E; Andreu D
FEBS Lett; 1993 Sep; 330(3):253-9. PubMed ID: 7690714
[TBL] [Abstract][Full Text] [Related]
25. Conformational flexibility in a highly mobile protein loop of foot-and-mouth disease virus: distinct structural requirements for integrin and antibody binding.
Feliu JX; Benito A; Oliva B; Avilés FX; Villaverde A
J Mol Biol; 1998 Oct; 283(2):331-8. PubMed ID: 9769208
[TBL] [Abstract][Full Text] [Related]
26. A second RGD motif in the 1D capsid protein of a SAT1 type foot-and-mouth disease virus field isolate is not essential for attachment to target cells.
Storey P; Theron J; Maree FF; O'Neill HG
Virus Res; 2007 Mar; 124(1-2):184-92. PubMed ID: 17161881
[TBL] [Abstract][Full Text] [Related]
27. RGD-containing peptides of VP1 of foot-and-mouth disease virus (FMDV) prevent virus infection in vitro.
Liebermann H; Dölling R; Schmidt D; Thalmann G
Acta Virol; 1991 Jan; 35(1):90-3. PubMed ID: 1683122
[TBL] [Abstract][Full Text] [Related]
28. A single amino acid substitution in nonstructural protein 3A can mediate adaptation of foot-and-mouth disease virus to the guinea pig.
Núñez JI; Baranowski E; Molina N; Ruiz-Jarabo CM; Sánchez C; Domingo E; Sobrino F
J Virol; 2001 Apr; 75(8):3977-83. PubMed ID: 11264387
[TBL] [Abstract][Full Text] [Related]
29. Propagation of an attenuated virus by design: engineering a novel receptor for a noninfectious foot-and-mouth disease virus.
Rieder E; Berinstein A; Baxt B; Kang A; Mason PW
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10428-33. PubMed ID: 8816817
[TBL] [Abstract][Full Text] [Related]
30. Genetic variation of foot-and-mouth disease virus from field outbreaks to laboratory isolation.
Meyer RF; Pacciarini M; Hilyard EJ; Ferrari S; Vakharia VN; Donini G; Brocchi E; Molitor TW
Virus Res; 1994 Jun; 32(3):299-312. PubMed ID: 8079512
[TBL] [Abstract][Full Text] [Related]
31. Antibodies raised in a natural host and monoclonal antibodies recognize similar antigenic features of foot-and-mouth disease virus.
Mateu MG; Andreu D; Domingo E
Virology; 1995 Jun; 210(1):120-7. PubMed ID: 7793064
[TBL] [Abstract][Full Text] [Related]
32. Efficient neutralization of foot-and-mouth disease virus by monovalent antibody binding.
Verdaguer N; Fita I; Domingo E; Mateu MG
J Virol; 1997 Dec; 71(12):9813-6. PubMed ID: 9371652
[TBL] [Abstract][Full Text] [Related]
33. Perturbations in the surface structure of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity.
Curry S; Fry E; Blakemore W; Abu-Ghazaleh R; Jackson T; King A; Lea S; Newman J; Rowlands D; Stuart D
Structure; 1996 Feb; 4(2):135-45. PubMed ID: 8805520
[TBL] [Abstract][Full Text] [Related]
34. Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture.
Sobrino F; Dávila M; Ortín J; Domingo E
Virology; 1983 Jul; 128(2):310-8. PubMed ID: 6310859
[TBL] [Abstract][Full Text] [Related]
35. Structural comparison of two strains of foot-and-mouth disease virus subtype O1 and a laboratory antigenic variant, G67.
Lea S; Abu-Ghazaleh R; Blakemore W; Curry S; Fry E; Jackson T; King A; Logan D; Newman J; Stuart D
Structure; 1995 Jun; 3(6):571-80. PubMed ID: 8590018
[TBL] [Abstract][Full Text] [Related]
36. Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection.
Borrego B; Novella IS; Giralt E; Andreu D; Domingo E
J Virol; 1993 Oct; 67(10):6071-9. PubMed ID: 7690417
[TBL] [Abstract][Full Text] [Related]
37. Foot-and-mouth disease virus can utilize the C-terminal extension of coxsackievirus A9 VP1 for cell infection.
Leippert M; Pfaff E
J Gen Virol; 2001 Jul; 82(Pt 7):1703-1711. PubMed ID: 11413382
[TBL] [Abstract][Full Text] [Related]
38. [Is the Arg-Gly-Asp sequence the site for foot-and-mouth disease virus binding with cell receptor?].
Surovoĭ AIu; Ivanov VT; Chepurkin AV; Ivaniushchenkov VN; Driagalin NN
Bioorg Khim; 1988 Jul; 14(7):965-8. PubMed ID: 2847760
[TBL] [Abstract][Full Text] [Related]
39. Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif.
Brown F; Benkirane N; Limal D; Halimi H; Newman JF; Van Regenmortel MH; Briand JP; Muller S
Vaccine; 1999 Aug; 18(1-2):50-6. PubMed ID: 10501234
[TBL] [Abstract][Full Text] [Related]
40. Foot-and-Mouth Disease Virus Leader Protease Cleaves G3BP1 and G3BP2 and Inhibits Stress Granule Formation.
Visser LJ; Medina GN; Rabouw HH; de Groot RJ; Langereis MA; de Los Santos T; van Kuppeveld FJM
J Virol; 2019 Jan; 93(2):. PubMed ID: 30404792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
